MedTrace Logo

Novel SARS-CoV-2 Point-of-care Testing

NCT05034978 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-02-09

No results posted yet for this study

Summary

The aim of the project is to study the feasibility of implementing a novel point-of-care test (POCT) for rapid detection of SARS-CoV-2 infection. A CRISPR-based detection kit would be piloted for testing of suspected SARS-CoV-2 infection in healthcare setting, with the objectives of evaluating the performance of the new test in the detection of SARS-CoV-2, and assessing the practicability of the new test for diagnosing SARS-CoV-2 infection in healthcare settings.

Conditions

  • SARS-CoV2 Infection

Interventions

OTHER

no intervention

evaluating the performance of a novel point-of-care test

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05034978 on ClinicalTrials.gov